Abstract
e14508 Background: Colorectal adenocarcinoma (CRC) is a clinically and genetically heterogeneous disease driven by multiple pathways including the HER2 receptor tyrosine kinase pathway. This study ...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have